Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anti-TNFs’ Link To Cancer In Children Under Investigation By FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency is investigating approximately 30 reports of cancer in pediatric patients.
Advertisement

Related Content

FDA Warns Again Of Rare Cancer Associated With TNF Blockers
FDA Warns Again Of Rare Cancer Associated With TNF Blockers
TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry
TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry
FDA Calls Roche’s Arthritis Drug Actemra Effective Ahead Of Panel Meeting
J&J/Centocor Files Golimumab In Three Indications
FDA Panel To Mull Risks Of Amgen’s Enbrel For Pediatric Psoriasis
UCB’s Cimzia Priced At Discount To Humira
Abbott’s Humira Approved For Juvenile Idiopathic Arthritis
Abbott’s Humira Approved For Juvenile Idiopathic Arthritis

Topics

Advertisement
UsernamePublicRestriction

Register

PS068018

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel